Search

Your search keyword '"Tekmal, Rajeshwar R."' showing total 273 results
Start Over Author "Tekmal, Rajeshwar R."
273 results on '"Tekmal, Rajeshwar R."'

1. Pharmacological inhibition of the LIF/LIFR autocrine loop reveals vulnerability of ovarian cancer cells to ferroptosis

Author

Ebrahimi, Behnam, Viswanadhapalli, Suryavathi, Pratap, Uday P., Rahul, Gopalam, Yang, Xue, Pitta Venkata, Prabhakar, Drel, Viktor, Santhamma, Bindu, Konda, Swapna, Li, Xiaonan, Sanchez, Alondra Lee Rodriguez, Yan, Hui, Sareddy, Gangadhara R., Xu, Zhenming, Singh, Brij B., Valente, Philip T., Chen, Yidong, Lai, Zhao, Rao, Manjeet, Kost, Edward R., Curiel, Tyler, Tekmal, Rajeshwar R., Nair, Hareesh B., and Vadlamudi, Ratna K.

Published
2024
Full Text
View/download PDF

2. Author Correction: Targeting LIPA independent of its lipase activity is a therapeutic strategy in solid tumors via induction of endoplasmic reticulum stress

Author

Liu, Xihui, Viswanadhapalli, Suryavathi, Kumar, Shourya, Lee, Tae-Kyung, Moore, Andrew, Ma, Shihong, Chen, Liping, Hsieh, Michael, Li, Mengxing, Sareddy, Gangadhara R., Parra, Karla, Blatt, Eliot B., Reese, Tanner C., Zhao, Yuting, Chang, Annabel, Yan, Hui, Xu, Zhenming, Pratap, Uday P., Liu, Zexuan, Roggero, Carlos M., Tan, Zhenqiu, Weintraub, Susan T., Peng, Yan, Tekmal, Rajeshwar R., Arteaga, Carlos L., Lippincott-Schwartz, Jennifer, Vadlamudi, Ratna K., Ahn, Jung-Mo, and Raj, Ganesh V.

Published
2024
Full Text
View/download PDF

3. Pharmacological inhibition of KDM1A/LSD1 enhances estrogen receptor beta-mediated tumor suppression in ovarian cancer

Author

Venkata, Prabhakar Pitta, Jayamohan, Sridharan, He, Yi, Alejo, Salvador, Johnson, Jessica D., Palacios, Bridgitte E., Pratap, Uday P., Chen, Yihong, Liu, Zexuan, Zou, Yi, Lai, Zhao, Suzuki, Takayoshi, Viswanadhapalli, Suryavathi, Weintraub, Susan T., Palakurthi, Srinath, Valente, Philip T., Tekmal, Rajeshwar R., Kost, Edward R., Vadlamudi, Ratna K., and Sareddy, Gangadhara R.

Published
2023
Full Text
View/download PDF

4. Targeting LIPA independent of its lipase activity is a therapeutic strategy in solid tumors via induction of endoplasmic reticulum stress

Author

Liu, Xihui, Viswanadhapalli, Suryavathi, Kumar, Shourya, Lee, Tae-Kyung, Moore, Andrew, Ma, Shihong, Chen, Liping, Hsieh, Michael, Li, Mengxing, Sareddy, Gangadhara R., Parra, Karla, Blatt, Eliot B., Reese, Tanner C., Zhao, Yuting, Chang, Annabel, Yan, Hui, Xu, Zhenming, Pratap, Uday P., Liu, Zexuan, Roggero, Carlos M., Tan, Zhenqiu, Weintraub, Susan T., Peng, Yan, Tekmal, Rajeshwar R., Arteaga, Carlos L., Lippincott-Schwartz, Jennifer, Vadlamudi, Ratna K., Ahn, Jung-Mo, and Raj, Ganesh V.

Published
2022
Full Text
View/download PDF

8. Data from Preclinical Development of Brain Permeable ERβ Agonist for the Treatment of Glioblastoma

Author

Pratap, Uday P., primary, Tidwell, Michael, primary, Balinda, Henriette U., primary, Clanton, Nicholas A., primary, Yang, Xue, primary, Viswanadhapalli, Suryavathi, primary, Sareddy, Gangadhara R., primary, Liang, Dong, primary, Xie, Huan, primary, Chen, Yidong, primary, Lai, Zhao, primary, Tekmal, Rajeshwar R., primary, McHardy, Stanton F., primary, Brenner, Andrew J., primary, and Vadlamudi, Ratna K., primary

Published
2023
Full Text
View/download PDF

9. Supplementary Fig. S2 from Preclinical Development of Brain Permeable ERβ Agonist for the Treatment of Glioblastoma

Author

Pratap, Uday P., primary, Tidwell, Michael, primary, Balinda, Henriette U., primary, Clanton, Nicholas A., primary, Yang, Xue, primary, Viswanadhapalli, Suryavathi, primary, Sareddy, Gangadhara R., primary, Liang, Dong, primary, Xie, Huan, primary, Chen, Yidong, primary, Lai, Zhao, primary, Tekmal, Rajeshwar R., primary, McHardy, Stanton F., primary, Brenner, Andrew J., primary, and Vadlamudi, Ratna K., primary

Published
2023
Full Text
View/download PDF

10. LIF/LIFR oncogenic signaling is a novel therapeutic target in endometrial cancer

Author

Tang, Weiwei, Ramasamy, Kumaraguruparan, Pillai, Sureshkumar M. A., Santhamma, Bindu, Konda, Swapna, Pitta Venkata, Prabhakar, Blankenship, Logan, Liu, Junhao, Liu, Zexuan, Altwegg, Kristin A., Ebrahimi, Behnam, Pratap, Uday P., Li, Xiaonan, Valente, Philip T., Kost, Edward, Sareddy, Gangadhara R., Vadlamudi, Ratna K., Nair, Hareesh B., Tekmal, Rajeshwar R., and Viswanadhapalli, Suryavathi

Published
2021
Full Text
View/download PDF

11. LIFR inhibition enhances the therapeutic efficacy of HDAC inhibitors in triple negative breast cancer

Author

Li, Mengxing, Viswanadhapalli, Suryavathi, Santhamma, Bindu, Pratap, Uday P., Luo, Yiliao, Liu, Junhao, Altwegg, Kristin A., Tang, Weiwei, Liu, Zexuan, Li, Xiaonan, Ebrahimi, Behnam, Yan, Hui, Zou, Yi, Konda, Swapna, Sareddy, Gangadhara R., Xu, Zhenming, Chen, Yidong, Rao, Manjeet K., Brenner, Andrew J., Kaklamani, Virginia G., Tekmal, Rajeshwar R., Ahmed, Gulzar, Raj, Ganesh V., Nickisch, Klaus J., Nair, Hareesh B., and Vadlamudi, Ratna K.

Published
2021
Full Text
View/download PDF

16. Abstract 6263: Lysine-specific histone demethylase 1A (KDM1A/LSD1) inhibition attenuates DNA double-strand break repair and augments efficacy of temozolomide in glioblastoma

Author

Alejo, Salvador, primary, Palacios, Bridgitte, additional, Venkata, Prabhakar Pitta, additional, Yi, He, additional, Li, Wenjing, additional, Johnson, Jessica, additional, Jayamohan, Sridharan, additional, Zhao, Weixing, additional, Zheng, Siyuan, additional, Suzuki, Takayoshi, additional, Tekmal, Rajeshwar R., additional, Brenner, Andrew, additional, Vadlamudi, Ratna K., additional, and Sareddy, Gangadhara R., additional

Published
2023
Full Text
View/download PDF

17. Abstract 4966: Targeting LIF/LIFR autocrine loops with EC359 in ovarian cancer: A novel LIFR targeted therapy

Author

Ebrahimi, Behnam, primary, Viswanadhapalli, Suryavathi, additional, Pratap, Uday P., additional, Gopalam, Rahul, additional, Yang, Xue, additional, Santhamma, Bindhu, additional, Konda, Swapna, additional, Li, Xiaonan, additional, Yan, Hui, additional, Sareddy, Gangadhara R., additional, Xu, Zhenming, additional, Kost, Edward R., additional, Tekmal, Rajeshwar R., additional, Nair, Hareesh B., additional, and Vadlamudi, Ratna K., additional

Published
2023
Full Text
View/download PDF

18. Abstract 3081: KDM1A/LSD1 inhibition enhances estrogen receptor beta mediated tumor suppression in ovarian cancer

Author

Venkata, Prabhakar P., primary, Jayamohan, Sridharan, additional, He, Yi, additional, Alejo, Salvador, additional, Johnson, Jessica D., additional, Pratap, Uday P., additional, Viswanadhapalli, Suryavathi, additional, Weintraub, Susan, additional, Tekmal, Rajeshwar R., additional, Vadlamudi, Ratna K., additional, Kost, Edward, additional, and Sareddy, Gangadhara R., additional

Published
2023
Full Text
View/download PDF

19. Abstract 3408: The role of obesity in promoting the LIF/LIFR signaling in triple negative breast cancer

Author

Randolph, Lois, primary, Sanchez, Alondra Rodriguez, additional, Blankenship, Logan, additional, Pratap, Uday P., additional, Yang, Xue, additional, Panneerdoss, Durga Meenakshi, additional, Konda, Swapna, additional, Santhamma, Bindu, additional, Sareddy, Gangadhara R., additional, Rao, Manjeet K., additional, Kost, Edward R., additional, Tekmal, Rajeshwar R., additional, Nair, Hareesh B., additional, Vadlamudi, Ratna K., additional, and Viswanadhapalli, Suryavathi, additional

Published
2023
Full Text
View/download PDF

22. Data from EC359: A First-in-Class Small-Molecule Inhibitor for Targeting Oncogenic LIFR Signaling in Triple-Negative Breast Cancer

Author

Viswanadhapalli, Suryavathi, primary, Luo, Yiliao, primary, Sareddy, Gangadhara R., primary, Santhamma, Bindu, primary, Zhou, Mei, primary, Li, Mengxing, primary, Ma, Shihong, primary, Sonavane, Rajni, primary, Pratap, Uday P., primary, Altwegg, Kristin A., primary, Li, Xiaonan, primary, Chang, Annabel, primary, Chávez-Riveros, Alejandra, primary, Dileep, Kalarickal V., primary, Zhang, Kam Y.J., primary, Pan, Xinlei, primary, Murali, Ramachandran, primary, Bajda, Marek, primary, Raj, Ganesh V., primary, Brenner, Andrew J., primary, Manthati, Vijaya, primary, Rao, Manjeet K., primary, Tekmal, Rajeshwar R., primary, Nair, Hareesh B., primary, Nickisch, Klaus J., primary, and Vadlamudi, Ratna K., primary

Published
2023
Full Text
View/download PDF

23. Supplementary Methods from EC359: A First-in-Class Small-Molecule Inhibitor for Targeting Oncogenic LIFR Signaling in Triple-Negative Breast Cancer

Author

Viswanadhapalli, Suryavathi, primary, Luo, Yiliao, primary, Sareddy, Gangadhara R., primary, Santhamma, Bindu, primary, Zhou, Mei, primary, Li, Mengxing, primary, Ma, Shihong, primary, Sonavane, Rajni, primary, Pratap, Uday P., primary, Altwegg, Kristin A., primary, Li, Xiaonan, primary, Chang, Annabel, primary, Chávez-Riveros, Alejandra, primary, Dileep, Kalarickal V., primary, Zhang, Kam Y.J., primary, Pan, Xinlei, primary, Murali, Ramachandran, primary, Bajda, Marek, primary, Raj, Ganesh V., primary, Brenner, Andrew J., primary, Manthati, Vijaya, primary, Rao, Manjeet K., primary, Tekmal, Rajeshwar R., primary, Nair, Hareesh B., primary, Nickisch, Klaus J., primary, and Vadlamudi, Ratna K., primary

Published
2023
Full Text
View/download PDF

24. Supplementary Figures S1-10 and Table S1 from EC359: A First-in-Class Small-Molecule Inhibitor for Targeting Oncogenic LIFR Signaling in Triple-Negative Breast Cancer

Author

Viswanadhapalli, Suryavathi, primary, Luo, Yiliao, primary, Sareddy, Gangadhara R., primary, Santhamma, Bindu, primary, Zhou, Mei, primary, Li, Mengxing, primary, Ma, Shihong, primary, Sonavane, Rajni, primary, Pratap, Uday P., primary, Altwegg, Kristin A., primary, Li, Xiaonan, primary, Chang, Annabel, primary, Chávez-Riveros, Alejandra, primary, Dileep, Kalarickal V., primary, Zhang, Kam Y.J., primary, Pan, Xinlei, primary, Murali, Ramachandran, primary, Bajda, Marek, primary, Raj, Ganesh V., primary, Brenner, Andrew J., primary, Manthati, Vijaya, primary, Rao, Manjeet K., primary, Tekmal, Rajeshwar R., primary, Nair, Hareesh B., primary, Nickisch, Klaus J., primary, and Vadlamudi, Ratna K., primary

Published
2023
Full Text
View/download PDF

25. Data from A First-in-Class Inhibitor of ER Coregulator PELP1 Targets ER+ Breast Cancer

Author

Altwegg, Kristin A., primary, Viswanadhapalli, Suryavathi, primary, Mann, Monica, primary, Chakravarty, Dimple, primary, Krishnan, Samaya, primary, Liu, Zexuan, primary, Liu, Junhao, primary, Pratap, Uday P., primary, Ebrahimi, Behnam, primary, Sanchez, John R., primary, Li, Xiaonan, primary, Ma, Shihong, primary, Park, Ben H., primary, Santhamma, Bindu, primary, Chen, Yidong, primary, Lai, Zhao, primary, Raj, Ganesh V., primary, Yuan, Yaxia, primary, Zhou, Daohong, primary, Sareddy, Gangadhara R., primary, Tekmal, Rajeshwar R., primary, McHardy, Stan, primary, Huang, Tim H.-M., primary, Rao, Manjeet K., primary, Vankayalapati, Hariprasad, primary, and Vadlamudi, Ratna K., primary

Published
2023
Full Text
View/download PDF

26. Supplementary Data from A First-in-Class Inhibitor of ER Coregulator PELP1 Targets ER+ Breast Cancer

Author

Altwegg, Kristin A., primary, Viswanadhapalli, Suryavathi, primary, Mann, Monica, primary, Chakravarty, Dimple, primary, Krishnan, Samaya, primary, Liu, Zexuan, primary, Liu, Junhao, primary, Pratap, Uday P., primary, Ebrahimi, Behnam, primary, Sanchez, John R., primary, Li, Xiaonan, primary, Ma, Shihong, primary, Park, Ben H., primary, Santhamma, Bindu, primary, Chen, Yidong, primary, Lai, Zhao, primary, Raj, Ganesh V., primary, Yuan, Yaxia, primary, Zhou, Daohong, primary, Sareddy, Gangadhara R., primary, Tekmal, Rajeshwar R., primary, McHardy, Stan, primary, Huang, Tim H.-M., primary, Rao, Manjeet K., primary, Vankayalapati, Hariprasad, primary, and Vadlamudi, Ratna K., primary

Published
2023
Full Text
View/download PDF

27. Supplementary Figure from A First-in-Class Inhibitor of ER Coregulator PELP1 Targets ER+ Breast Cancer

Author

Altwegg, Kristin A., primary, Viswanadhapalli, Suryavathi, primary, Mann, Monica, primary, Chakravarty, Dimple, primary, Krishnan, Samaya, primary, Liu, Zexuan, primary, Liu, Junhao, primary, Pratap, Uday P., primary, Ebrahimi, Behnam, primary, Sanchez, John R., primary, Li, Xiaonan, primary, Ma, Shihong, primary, Park, Ben H., primary, Santhamma, Bindu, primary, Chen, Yidong, primary, Lai, Zhao, primary, Raj, Ganesh V., primary, Yuan, Yaxia, primary, Zhou, Daohong, primary, Sareddy, Gangadhara R., primary, Tekmal, Rajeshwar R., primary, McHardy, Stan, primary, Huang, Tim H.-M., primary, Rao, Manjeet K., primary, Vankayalapati, Hariprasad, primary, and Vadlamudi, Ratna K., primary

Published
2023
Full Text
View/download PDF

31. Lysine-specific histone demethylase 1A (KDM1A/LSD1) inhibition attenuates DNA double strand break repair and augments efficacy of temozolomide in glioblastoma

Author

Alejo, Salvador, primary, Palacios, Bridgitte E, additional, Venkata, Prabhakar Pitta, additional, He, Yi, additional, Li, Wenjing, additional, Johnson, Jessica D, additional, Yihong, Chen, additional, Jayamohan, Sridharan, additional, Pratap, Uday P, additional, Clarke, Kyra, additional, Zou, Yi, additional, Lv, Yingli, additional, Weldon, Korri, additional, Viswanadhapalli, Suryavathi, additional, Lai, Zhao, additional, Ye, Zhenqing, additional, Chen, Yidong, additional, Gilbert, Andrea R, additional, Suzuki, Takayoshi, additional, Tekmal, Rajeshwar R, additional, Zhao, Weixing, additional, Zheng, Siyuan, additional, Vadlamudi, Ratna K, additional, Brenner, Andrew J, additional, and Sareddy, Gangadhara R, additional

Published
2023
Full Text
View/download PDF

32. Brain-Derived Estrogen and Neurological Disorders

Author

Brann, Darrell W., primary, Lu, Yujiao, additional, Wang, Jing, additional, Sareddy, Gangadhara R., additional, Pratap, Uday P., additional, Zhang, Quanguang, additional, Tekmal, Rajeshwar R., additional, and Vadlamudi, Ratna K., additional

Published
2022
Full Text
View/download PDF

33. Inhibition of LIFR Blocks Adiposity-Driven Endometrioid Endometrial Cancer Growth

Author

Blankenship, Logan, primary, Pratap, Uday P., additional, Yang, Xue, additional, Liu, Zexuan, additional, Altwegg, Kristin A., additional, Santhamma, Bindu, additional, Ramasamy, Kumaraguruparan, additional, Konda, Swapna, additional, Chen, Yidong, additional, Lai, Zhao, additional, Zheng, Siyuan, additional, Sareddy, Gangadhara R., additional, Valente, Philip T., additional, Kost, Edward R., additional, Nair, Hareesh B., additional, Tekmal, Rajeshwar R., additional, Vadlamudi, Ratna K., additional, and Viswanadhapalli, Suryavathi, additional

Published
2022
Full Text
View/download PDF

35. A First-in-Class Inhibitor of ER Coregulator PELP1 Targets ER+ Breast Cancer

Author

Altwegg, Kristin A., primary, Viswanadhapalli, Suryavathi, additional, Mann, Monica, additional, Chakravarty, Dimple, additional, Krishnan, Samaya, additional, Liu, Zexuan, additional, Liu, Junhao, additional, Pratap, Uday P., additional, Ebrahimi, Behnam, additional, Sanchez, John R., additional, Li, Xiaonan, additional, Ma, Shihong, additional, Park, Ben H., additional, Santhamma, Bindu, additional, Chen, Yidong, additional, Lai, Zhao, additional, Raj, Ganesh V., additional, Yuan, Yaxia, additional, Zhou, Daohong, additional, Sareddy, Gangadhara R., additional, Tekmal, Rajeshwar R., additional, McHardy, Stan, additional, Huang, Tim H.-M., additional, Rao, Manjeet K., additional, Vankayalapati, Hariprasad, additional, and Vadlamudi, Ratna K., additional

Published
2022
Full Text
View/download PDF

37. Lysine-specific histone demethylase 1A (KDM1A/LSD1) inhibition attenuates DNA double-strand break repair and augments the efficacy of temozolomide in glioblastoma.

Author

Alejo, Salvador, Palacios, Bridgitte E, Venkata, Prabhakar Pitta, He, Yi, Li, Wenjing, Johnson, Jessica D, Chen, Yihong, Jayamohan, Sridharan, Pratap, Uday P, Clarke, Kyra, Zou, Yi, Lv, Yingli, Weldon, Korri, Viswanadhapalli, Suryavathi, Lai, Zhao, Ye, Zhenqing, Chen, Yidong, Gilbert, Andrea R, Suzuki, Takayoshi, and Tekmal, Rajeshwar R

Published
2023
Full Text
View/download PDF

40. Abstract 891: Therapeutic targeting of ovarian cancer stem cells using estrogen receptor beta agonist

Author

He, Yi, primary, Alejo, Salvador, additional, Venkata, Prabhakar P., additional, Johnson, Jessica D., additional, Loeffel, Ilanna, additional, Martel, Julie Ann, additional, Pratap, Uday P., additional, Viswanadhapalli, Suryavathi, additional, Tekmal, Rajeshwar R., additional, Vadlamudi, Ratna K., additional, Kost, Edward, additional, and Sareddy, Gangadhara R., additional

Published
2022
Full Text
View/download PDF

42. Abstract P5-10-01: Leukemia inhibitory factor receptor inhibition reduces obesity driven progression of triple negative breast cancer

Author

Viswanadhapalli, Suryavathi, primary, Pratap, Uday P, additional, Ebrahimi, Behnam, additional, Blankenship, Logan, additional, Joshi, Jaitri, additional, Liu, Zexuan, additional, Altwegg, Kristin A, additional, Li, Xiaonan, additional, Sareddy, Gangadhara R, additional, Santhamma, Bindu, additional, Konda, Swapna, additional, Rao, Manjeet, additional, Kost, Edward, additional, Tekmal, Rajeshwar R, additional, Nair, Hareesh B, additional, and Vadlamudi, Ratna K, additional

Published
2022
Full Text
View/download PDF

43. KDM1A inhibition augments the efficacy of rapamycin for the treatment of endometrial cancer

Author

Venkata, Prabhakar Pitta, primary, Chen, Yihong, additional, Alejo, Salvador, additional, He, Yi, additional, Palacios, Bridgitte E., additional, Loeffel, Ilanna, additional, Liu, Junhao, additional, Pratap, Uday P., additional, Gray, Gabrielle, additional, Achuthan Pillai, Sureshkumar Mulampurath, additional, Zou, Yi, additional, Lai, Zhao, additional, Suzuki, Takayoshi, additional, Viswanadhapalli, Suryavathi, additional, Palakurthi, Srinath, additional, Tekmal, Rajeshwar R., additional, Vadlamudi, Ratna K., additional, Kost, Edward, additional, and Sareddy, Gangadhara R., additional

Published
2022
Full Text
View/download PDF

45. A phosphotyrosine switch determines the antitumor activity of ER β

Author

Yuan, Bin, Cheng, Long, Chiang, Huai-Chin, Xu, Xiaojie, Han, Yongjian, Su, Hang, Wang, Lingxue, Zhang, Bo, Lin, Jing, Li, Xiaobing, Xie, Xiangyang, Wang, Tao, Tekmal, Rajeshwar R., Curiel, Tyler J., Yuan, Zhi-Min, Elledge, Richard, Hu, Yanfen, Ye, Qinong, and Li, Rong

Subjects
Tyrosine -- Physiological aspects -- Research, Estrogen -- Receptors, Breast cancer -- Development and progression -- Research, Health care industry
Abstract

Estrogen receptors ER α and ER β share considerable sequence homology yet exert opposite effects on breast cancer cell proliferation. While the proliferative role of ER α in breast tumors is well characterized, it is not clear whether the antitumor activity of ERβ can be mobilized in breast cancer cells. Here, we have shown that phosphorylation of a tyrosine residue (Y36) present in ER β, but not in ER α, dictates ER β-specific activation of transcription and is required for ER β-dependent inhibition of cancer cell growth in culture and in murine xenografts. Additionally, the c-ABL tyrosine kinase and EYA2 phosphatase directly and diametrically controlled the phosphorylation status of Y36 and subsequent ER β function. A nonphosphorylatable, transcriptionally active ER β mutant retained antitumor activity but circumvented control by upstream regulators. Phosphorylation of Y36 was required for ER β-mediated coactivator recruitment to ER β target promoters. In human breast cancer samples, elevated phosphorylation of Y36 in ER β correlated with high levels of c-ABL but low EYA2 levels. Furthermore, compared with total ER β, the presence of phosphorylated Y36-specific ER β was strongly associated with both disease-free and overall survival in patients with stage II and III disease. Together, these data identify a signaling circuitry that regulates ER β-specific antitumor activity and has potential as both a prognostic tool and a molecular target for cancer therapy., Introduction The 2 estrogen receptors ER α and ER β mediate diverse effects of estrogens in multiple tissues (1). Despite considerable sequence homology, ER α and ER β carry out [...]

Published
2014
Full Text
View/download PDF

49. Abstract 1253: Therapeutic targeting of endometrial cancer with novel LIFR inhibitor EC359

Author

Tang, Weiwei, primary, Ramasamy, Kumaraguruparan, additional, Pillai, Sureshkumar M., additional, Santhamma, Bindu, additional, Konda, Swapna, additional, Vekata, Prabhakar P., additional, Blankenship, Logan, additional, Liu, Junhao, additional, Liu, Zexuan, additional, Altwegg, Kristin A., additional, Ebrahimi, Behnam, additional, Pratap, Uday P., additional, Li, Xiaonan, additional, Kost, Edward, additional, Sareddy, Gangadhara R., additional, Vadlamudi, Ratna K., additional, Nair, Hareesh B., additional, Tekmal, Rajeshwar R., additional, and Viswanadhapalli, Suryavathi, additional

Published
2021
Full Text
View/download PDF

50. Abstract 2026: KDM1A inhibition augment ER stress inducers efficacy to reduce glioblastoma stemness

Author

He, Yi, primary, Venkata, Prabhakar Pitta, additional, Alejo, Salvador, additional, Chen, Yihong, additional, Palacios, Bridgitte, additional, Gray, Gabrielle, additional, Pratap, Uday P., additional, Viswanadhapalli, Suryavathi, additional, Zheng, Siyuan, additional, Tekmal, Rajeshwar R., additional, Brenner, Andrew J., additional, and Sareddy, Gangadhara R., additional

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results